What PE-Backed CEOs Need in the First 100 Days
The first hundred days set the terms of the entire hold period. The agenda is diagnosis, alignment and two or three visible wins — in that order.
A CEO stepping into a PE-backed company inherits two clocks. The first belongs to the business: customers, people, operations moving at their own pace. The second belongs to the fund: a value-creation plan with a timeline that does not negotiate.
The first hundred days are where these clocks are synchronized — or where the divergence begins that the rest of the hold period will spend correcting.
The sequence that works is unfashionable in its patience. Diagnose before you announce. The new CEO who arrives with a transformation plan on day one has usually mistaken confidence for insight. Thirty days of structured listening — customers, the second line of management, the numbers behind the numbers — produces a diagnosis the organization recognizes as true. That recognition is the foundation of every subsequent mandate.
Alignment comes next, and it is specific: agreement with the board on what the business is optimizing for, in what order, with what trade-offs acknowledged in writing. Growth versus margin. Organic versus acquired. The CEOs who struggle are rarely wrong about the business; they are unaligned with the board about the priority of their correct ideas.
Then, and only then, visible wins — two or three, chosen for symbolism as much as substance. A pricing correction that signals commercial rigour. A long-avoided people decision that signals standards. These are not cosmetic. They are how a new operating cadence announces itself.
The hundred days end not with a plan, but with a rhythm: a monthly operating review that the organization trusts, a short list of value-creation priorities, and a leadership team that knows what winning looks like this year.
